Product Name | Zandelisib |
Synonyms | Zandelisib;8Z28M5SX0X;4-yl)-1,3,5-triazin-2-amine;[2-(1-methylpiperidin-4-yl)phenyl]propan-2-yl}-6-(morpholin-;4-[2-(difluoromethyl)-1H-benzimidazol-1-yl]-N-{2-methyl-1-;Zandelisib [INN];Zandelisib [USAN];GTPL10627;ME401;WHO 11202;Example 51 [WO2012135160A1];A35 [WO2012135160A1];1,3,5-Triazin-2-amine, 4-(2-(difluoromethyl)-1H-benzimidazol-1-yl)-N-(1,1-dimethyl-2-(2-(1-methyl-4-piperidinyl)pheny |
Catalog No. | A-2006 |
CAS No. | 1401436-95-0 |
Molecular Formula | C31H38F2N8O |
Molecular Weight | 576.6832 |
Smile Code | CC(C)(CC1=CC=CC=C1C2CCN(CC2)C)NC3=NC(=NC(=N3)N4CCOCC4)N5C6=CC=CC=C6N=C5C(F)F |
InChI | 1S/C31H38F2N8O/c1-31(2,20-22-8-4-5-9-23(22)21-12-14-39(3)15-13-21)38-28-35-29(40-16-18-42-19-17-40)37-30(36-28)41-25-11-7-6-10-24(25)34-27(41)26(32)33/h4-11,21,26H,12-20H2,1-3H3,(H,35,36,37,38) |
EINECS | |
Density | |
Melting point | |
Boiling point | |
Refractive index | |
Water solubility | |
Hazard Symbols | |
Risk Codes | |
Safety Description |